ArticleBioactive materials2026
A viscoelastic suspension culture strategy modulating fusion and development in blood vessel organoids.
Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human blood vessel organoids (hBVOs) demonstrate significant potential in vascular drug development and tissue repair engineering. However, the traditional liquid culture method leads to spontaneous cell fusion and lacks a defined mechanical microenvironment to support cell growth during the initial suspension culture process for hBVOs, which limits their homogeneity under large-scale cultivation and the stability of their angiogenic properties. This study developed a novel viscoelastic culture medium with dual mechanical functions to replace the conventional liquid culture medium. By adding xanthan gum, we constructed a "rigid" barrier that could resist the transient stress generated under external disturbances, thereby inhibiting the contact and fusion of hBVOs. Concurrently, the system exhibits stress-relaxing "soft" properties in response to long-term stresses arising from hBVOs growth and expansion, providing appropriate mechanical cues while supporting cell growth. Our approach elevated hBVOs residual proportion from 31.35% to 84.23%, while significantly reducing size coefficient variation from 0.53 to 0.21. Furthermore, this viscoelastic medium can promote the densification and pre-vascularization of the internal tissues of hBVOs. Compared with traditional liquid culture hBVOs, after embedding them in type I collagen gel, they exhibit a stronger angiogenic ability, with the total length of blood vessels increasing by 124.1%. Transcriptomic analysis further confirms that this environment upregulates pathways related to mechanotransduction and angiogenesis. This study not only provides a novel strategy for the efficient, standardised preparation of hBVOs but also offers fresh perspectives for research into mechanically regulated vascular development within microenvironments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.